
StockStory pointed to Stryker’s revenue growth and wider free cash flow margin as its shares lagged the broader market over six months.
Stryker shares fell 20% over six months, compared with a 12.8% gain for the S&P 500, StockStory reported on Oct. 12. As of 20:02 UTC that day, shares traded at $282.60, up 1.9% since the previous close.
StockStory’s analysis said Stryker’s organic revenue averaged 9.2% year-over-year growth over the prior two years. It also cited $25.84 billion in revenue over the past 12 months.
The publisher said the company’s free cash flow margin rose 6.5 percentage points over five years, reaching 18.2% for the trailing 12 months. Its report cited a forward P/E of 17.4 times at a share price of $277.82.
This article was produced with the help of AI technology. Source: Yahoo Finance